The impact of stigma on cognitive performance; risk factor dissonance among young black MSM; pregnancy and the HIV care continuum; new data on pediatric raltegravir use.
Efavirenz (Sustiva, Stocrin) use was associated with a 60% increased risk of neurological conditions in children, according to data presented at IDWeek 2018 in San Francisco.
Women with HIV tend to perform worse than HIV-negative women on cognitive performance tests, even after many years on treatment, new research finds -- but trends differed depending on the test and on women's treatment success.
Antiretroviral therapy reduced systemic and central nervous system (CNS) inflammation in past substance users compared with nonusers, according to the results of a study presented at IDWeek 2016.
Several diseases and behaviors are linked to decreased mental function in older HIV-positive men compared with older men without HIV, according to results of a careful comparison.
A study by Ashby and colleagues aimed to characterise the neurocognitive function of young adults with perinatally acquired HIV (paHIV) infection and compare them to their HIV negative siblings or family members as aged matched controls.
The study h...
Neurologic disease is frequently associated with HIV infection. Both the central nervous system (CNS) and the peripheral nervous system (PNS) may be affected. The causes of neurological disease are various: autoimmune reactions due to immune disregul...